PSP Research’s KalVista Pharmaceuticals KALV Stock Holding History

PSP Research’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,795	Closed	-$217K	–	83
2026 Q1	$217K	Buy	+10,795	New	+$174K	0.15%	67

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PSP Research's KALV Position: Q2 2026 in Review

PSP Research sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 10,795 shares — an estimated $217K sold.

PSP Research first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $217K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

PSP Research reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
PSP Research sold 10,795 KalVista Pharmaceuticals shares in Q2 2026, an estimated $217K.
PSP Research first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
PSP Research's KalVista Pharmaceuticals position peaked at $217K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on PSP Research's 13F filing for Q2 2026, filed 9 Jul 2026.